2024 Q4 Form 10-Q Financial Statement

#000159991624000309 Filed on December 05, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q4
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $83.25K $55.25K
YoY Change 50.68% 1039.15%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$83.25K -$55.25K
YoY Change 50.68%
Income Tax
% Of Pretax Income
Net Earnings -$83.25K -$55.25K
YoY Change 50.68% 1039.15%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 611.6M shares 611.6M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $300.00 $300.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $8.801K
Receivables
Other Receivables
Total Short-Term Assets $8.983K $9.101K $8.703K
YoY Change 3.22% -44.19%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $8.983K $9.101K $8.703K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $8.983K $9.101K $8.703K
YoY Change 3.22% -44.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $334.2K $258.7K $65.87K
YoY Change 407.45% 1192.98%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $334.2K $258.7K $65.87K
Total Long-Term Liabilities
Total Liabilities $334.2K $258.7K
YoY Change 1192.98%
SHAREHOLDERS EQUITY
Retained Earnings -$349.7K -$266.5K -$76.43K
YoY Change 357.54% 1157.94% 429.12%
Common Stock $611.6K $611.6K $611.6K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$325.3K -$249.6K -$57.17K
YoY Change
Total Liabilities & Shareholders Equity $8.983K $9.101K $8.703K
YoY Change 3.22% -44.19%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q4
OPERATING ACTIVITIES
Net Income -$83.25K -$55.25K
YoY Change 50.68% 1039.15%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $46.00 -$48.47K
YoY Change -100.09% 899.28%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $48.46K
YoY Change 899.26%
NET CHANGE
Cash From Operating Activities $46.00 -$48.47K
Cash From Investing Activities
Cash From Financing Activities $48.46K
Net Change In Cash $46.00 -$1.00
YoY Change -4700.0%
FREE CASH FLOW
Cash From Operating Activities $46.00 -$48.47K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q4 us-gaap Interest Paid
InterestPaid
usd
CY2024Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2024Q4 dei Amendment Flag
AmendmentFlag
false
CY2024Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
CY2024Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q4 dei Document Type
DocumentType
10-Q
CY2024Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q4 dei Document Period End Date
DocumentPeriodEndDate
2024-10-31
CY2024Q4 dei Entity File Number
EntityFileNumber
000-056358
CY2024Q4 dei Entity Registrant Name
EntityRegistrantName
Ultimate Holdings GROUP, Inc.
CY2024Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
92-3764731
CY2024Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q4 dei Entity Shell Company
EntityShellCompany
true
CY2024Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
611600000 shares
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
55249 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-55249 usd
CY2024Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q4 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-325262 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-55249 usd
CY2023Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
7603 usd
CY2024Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-41200 usd
CY2024Q4 UHGI Dueto Related Parties Proceeds Period
DuetoRelatedPartiesProceedsPeriod
124495 usd
CY2023Q4 UHGI Dueto Related Parties Proceeds Period
DuetoRelatedPartiesProceedsPeriod
45862 usd
CY2024Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001888846
CY2024Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
usd
CY2024Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2023Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
usd
CY2024Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
usd
CY2023Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
usd
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
usd
CY2023Q4 us-gaap Interest Paid
InterestPaid
usd
CY2023Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2024Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
300 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
300 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-266456 usd
CY2024Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7083 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-477 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
-325262 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-249573 usd
CY2024Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8983 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9101 usd
CY2024Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
83249 usd
CY2024Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-83249 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-55249 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-83249 usd
CY2024Q4 UHGI Goodwill Foreign Currency Translation Gain Lossperiod
GoodwillForeignCurrencyTranslationGainLossperiod
7560 usd
CY2023Q4 UHGI Goodwill Foreign Currency Translation Gain Lossperiod
GoodwillForeignCurrencyTranslationGainLossperiod
1784 usd
CY2024Q4 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-75689 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-53465 usd
CY2024Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2023Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2023Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
611600000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
611600000 shares
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-3700 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-55249 usd
CY2023Q4 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
1 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
611600000 shares
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-57165 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
611600000 shares
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-249573 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-83249 usd
CY2024Q4 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
7560 usd
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
611600000 shares
CY2024Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-325262 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-83249 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-55249 usd
CY2024Q4 UHGI Dueto Related Parties Proceeds Period
DuetoRelatedPartiesProceedsPeriod
124495 usd
CY2023Q4 UHGI Dueto Related Parties Proceeds Period
DuetoRelatedPartiesProceedsPeriod
45862 usd
CY2024Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
46 usd
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
300 usd
CY2024Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
300 usd
CY2024Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
8683 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
8801 usd
CY2024Q4 us-gaap Assets Current
AssetsCurrent
8983 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
9101 usd
CY2024Q4 us-gaap Assets
Assets
8983 usd
CY2024Q3 us-gaap Assets
Assets
9101 usd
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
41200 usd
CY2024Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
334245 usd
CY2024Q3 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
217474 usd
CY2024Q4 us-gaap Liabilities Current
LiabilitiesCurrent
334245 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
258674 usd
CY2024Q4 us-gaap Liabilities
Liabilities
334245 usd
CY2024Q3 us-gaap Liabilities
Liabilities
258674 usd
CY2024Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2024Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2024Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
611600000 shares
CY2024Q4 us-gaap Common Stock Value
CommonStockValue
611600 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
611600 usd
CY2024Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
-594240 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
-594240 usd
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-349705 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-266456 usd
CY2024Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7083 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-477 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
-325262 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-249573 usd
CY2024Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8983 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9101 usd
CY2024Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
83249 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
55249 usd
CY2024Q4 us-gaap Operating Expenses
OperatingExpenses
83249 usd
CY2024Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-83249 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-55249 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-83249 usd
CY2024Q4 UHGI Goodwill Foreign Currency Translation Gain Lossperiod
GoodwillForeignCurrencyTranslationGainLossperiod
7560 usd
CY2023Q4 UHGI Goodwill Foreign Currency Translation Gain Lossperiod
GoodwillForeignCurrencyTranslationGainLossperiod
1784 usd
CY2024Q4 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-75689 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-53465 usd
CY2024Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2023Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2024Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
611600000 shares
CY2023Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
611600000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
611600000 shares
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-3700 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-55249 usd
CY2023Q4 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
1 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-57165 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
611600000 shares
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-249573 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-83249 usd
CY2024Q4 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
7560 usd
CY2023Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
7603 usd
CY2024Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-41200 usd
CY2024Q4 UHGI Dueto Related Parties Proceeds Period
DuetoRelatedPartiesProceedsPeriod
124495 usd
CY2023Q4 UHGI Dueto Related Parties Proceeds Period
DuetoRelatedPartiesProceedsPeriod
45862 usd
CY2024Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
46 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1784 usd
CY2024Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-46 usd
CY2023Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1784 usd
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
300 usd
CY2024Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
300 usd
CY2024Q4 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zG4EhfJwPmz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="background-color: white"><b><span id="xdx_86F_zwEkzMt6wWj7">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on information available as of the date of the unaudited financial statements. Significant estimates required to be made by management include, but are not limited to, valuation allowance of deferred tax assets. Actual results could differ from the estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2024Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
46 usd
CY2023Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1784 usd
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
300 usd
CY2024Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
300 usd
CY2024Q4 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zG4EhfJwPmz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="background-color: white"><b><span id="xdx_86F_zwEkzMt6wWj7">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on information available as of the date of the unaudited financial statements. Significant estimates required to be made by management include, but are not limited to, valuation allowance of deferred tax assets. Actual results could differ from the estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2024Q4 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zG4EhfJwPmz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="background-color: white"><b><span id="xdx_86F_zwEkzMt6wWj7">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on information available as of the date of the unaudited financial statements. Significant estimates required to be made by management include, but are not limited to, valuation allowance of deferred tax assets. Actual results could differ from the estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2024Q4 UHGI Netlossasof
Netlossasof
83249 usd
CY2024Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
17482 usd
CY2024Q4 UHGI Paidbyharibinduring
Paidbyharibinduring
124495 usd
CY2023Q4 UHGI Paidbyharibinduring
Paidbyharibinduring
45862 usd
CY2024Q4 UHGI Duetoharibinasof
Duetoharibinasof
334245 usd
CY2024Q3 UHGI Duetoharibinasof
Duetoharibinasof
217474 usd
CY2024Q4 UHGI Netlossasof
Netlossasof
83249 usd
CY2024Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
17482 usd
CY2024Q4 UHGI Paidbyharibinduring
Paidbyharibinduring
124495 usd
CY2023Q4 UHGI Paidbyharibinduring
Paidbyharibinduring
45862 usd
CY2023Q4 UHGI Paidbyharibinduring
Paidbyharibinduring
45862 usd
CY2024Q4 UHGI Netlossasof
Netlossasof
83249 usd
CY2024Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
17482 usd
CY2024Q4 UHGI Paidbyharibinduring
Paidbyharibinduring
124495 usd
CY2023Q4 UHGI Paidbyharibinduring
Paidbyharibinduring
45862 usd
CY2023Q4 UHGI Paidbyharibinduring
Paidbyharibinduring
45862 usd
CY2024Q4 UHGI Duetoharibinasof
Duetoharibinasof
334245 usd
CY2024Q4 UHGI Duetoharibinasof
Duetoharibinasof
334245 usd
CY2024Q3 UHGI Duetoharibinasof
Duetoharibinasof
217474 usd
CY2024Q4 UHGI Additionalpaidbyharibin
Additionalpaidbyharibin
18268 usd
CY2024Q4 UHGI Duetoharibinasof
Duetoharibinasof
334245 usd
CY2024Q4 UHGI Additionalpaidbyharibin
Additionalpaidbyharibin
18268 usd
CY2024Q4 UHGI Additionalpaidbyharibin
Additionalpaidbyharibin
18268 usd

Files In Submission

Name View Source Status
0001599916-24-000309-index-headers.html Edgar Link pending
0001599916-24-000309-index.html Edgar Link pending
0001599916-24-000309.txt Edgar Link pending
0001599916-24-000309-xbrl.zip Edgar Link pending
exhibit31.htm Edgar Link pending
exhibit32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
uhgi-20241031.xsd Edgar Link pending
ultimate_10q125o.htm Edgar Link pending
uhgi-20241031_cal.xml Edgar Link unprocessable
uhgi-20241031_def.xml Edgar Link unprocessable
uhgi-20241031_pre.xml Edgar Link unprocessable
uhgi-20241031_lab.xml Edgar Link unprocessable
ultimate_10q125o_htm.xml Edgar Link completed